“…According to these results, major renal damage could be ruled out. This is in contrast to some works clearly showing renal damage by arsenic in humans (Meliker et al, 2007, Robles-Osorio et al, 2015, even in rodents (Shahid et al, 2014, Riaz et al, 2020, but the experimental design and epidemiology in humans have, sometimes, provided conflicting results (Samelo et al, 2020). However, it is known that these classical endpoints are not sensitive enough to detect early renal damage (Sabbisetti and Bonventre, 2012), and several molecules occurring in urine in the very early stages of renal injury have been found to be useful as biomarkers, such as neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule 1 (KIM-1), N-acetyl-ÎČ-D-glucosaminidase (NAG), liver fatty acid binding protein (L-FABP), heart fatty acid binding protein (H-FABP, also known as FABP3), tissue inhibitor metalloproteinase-2 (TIMP-2), insulin-like growth factor binding protein 7 (IGFBP-7), clusterin, and netrin, among others (Griffin et al, 2019;Schaub, 2016).…”